Literature DB >> 6054688

Urinary coproporphyrin isomer distribution in the Dubin-Johnson syndrome.

P Koskelo, I Toivonen, H Adlercreutz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6054688

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  7 in total

1.  Homozygous haemoglobin O disease and conjugated hyperbilirubinaemia in a Sudanese family.

Authors:  S A Ibrahim; D Mustafa; A O Mohamed; M B Mohed
Journal:  BMJ       Date:  1992-01-04

Review 2.  Hepatic transport and metabolism of various organic anions in patients with congenital non-hemolytic hyperbilirubinemia, including constitutional indocyanine green excretory defect.

Authors:  M Nambu; T Namihisa
Journal:  J Gastroenterol       Date:  1994-04       Impact factor: 7.527

3.  Genetic and biochemical study of dual hereditary jaundice: Dubin-Johnson and Gilbert's syndromes. Haplotyping and founder effect of deletion in ABCC2.

Authors:  Lenka Slachtova; Ondrej Seda; Jana Behunova; Martin Mistrik; Pavel Martasek
Journal:  Eur J Hum Genet       Date:  2015-09-09       Impact factor: 4.246

Review 4.  Gene replacement therapy for genetic hepatocellular jaundice.

Authors:  Remco van Dijk; Ulrich Beuers; Piter J Bosma
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

5.  Dubin-Johnson syndrome in a neonate.

Authors:  F Nakata; K Oyanagi; M Fujiwara; H Sogawa; R Minami; K Horino; T Nakao; T Kondo
Journal:  Eur J Pediatr       Date:  1979       Impact factor: 3.183

6.  Coproporphyrin I and 3 excretion in bile and urine.

Authors:  N Kaplowitz; N Javitt; A Kappas
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

7.  Endogenous Coproporphyrin I and III are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR-) Rats.

Authors:  Jacqueline Bezençon; Chitra Saran; Janine Hussner; James J Beaudoin; Yueping Zhang; Hong Shen; John K Fallon; Philip C Smith; Henriette E Meyer Zu Schwabedissen; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2020-10-13       Impact factor: 3.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.